Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01518608
Other study ID # 29237403/SMR-1651
Secondary ID
Status Completed
Phase Phase 4
First received August 25, 2011
Last updated January 25, 2012
Start date September 2009
Est. completion date October 2011

Study information

Verified date January 2012
Source Oslo University Hospital
Contact n/a
Is FDA regulated No
Health authority Norway: Ethics Committee
Study type Interventional

Clinical Trial Summary

Induction of anesthesia:

After 3 minutes pre-oxygenation with 100% oxygen, a blinded dose alfentanil (0,10,20,30,40,50 or 60 µg/kg, followed by thiopental 4 mg/kg and rocuronium 0.6 mg/kg will be administered over 15 sec. Laryngoscopy will be performed 40 s. after injection of rocuronium, with the goal being to have the endotracheal tube passed through the patients vocal cords and the cuff inflated within the following 15 s . The investigator performing the tracheal intubation is blinded to the dose of alfentanil administered.

Blood samples:

As part of the study efficacy, blood samples, will be collected prior to induction and 30 s., 1 min. 3 min. and 5 min postintubation to determine blood concentrations of alfentanil and catecholamines.


Description:

Introduction:

Autonomic responses (blood pressure and heart rate increases) secondary to tracheal intubation are probably not harmful to healthy individuals(1). However, in certain groups of patients (cardiac/neurosurgical/ophthalmic surgery), strict control of these responses during anesthesia may add to the safety of patient care (2-6).

Traditionally, rapid sequence induction (RSI) of anesthesia is performed with combined administration of pentothal and suxamethonium. Significant increases in blood pressure and heart rate will be observed in most patients when this drug regimen is used(7-9). Opioid drugs may obtund autonomic responses to tracheal stimulation(10), but at present there is no consensus regarding the use of opioids as an integral part of the RSI of anesthesia.

AIMS & OBJECTIVES:

- Define guidelines for proper care of cardiac/neurosurgical/eye surgery patients during induction of anesthesia when rapid airway control is needed.

- Determine the dose of alfentanil needed to prevent blood pressure and heart rate increases > 10% secondary to tracheal intubation performed in a rapid-sequence fashion (intubation completed within 70 s after start of drug administration: alfentanil-pentothal 4 mg/kg-rocuronium 0.6 mg/kg).

- Determine the optimal dose of alfentanil to obtain perfect conditions for tracheal intubation in healthy surgical patients when laryngoscopy is initiated within 55 s after start of drug administration (alfentanil-pentothal 4 mg/kg-rocuronium 0,6 mg/kg).

Induction of anesthesia:

After 3 min pre-oxygenation with 100% oxygen, a blinded dose of alfentanil (0, 10, 20, 30, 40, 50 or 60 mcg/kg), followed by thiopental 4 mg/kg and rocuronium 0.6 mg/kg will be administered over 15 s. Cricoid pressure will be applied when the patient is unconscious.

Laryngoscopy and intubation:

Laryngoscopy will be performed 40 s after injection of rocuronium, with the goal being to have the endotracheal tube passed through the patients vocal cords and the cuff inflated within the following 15 s. The investigator performing the tracheal intubation will be blinded to the dose of alfentanil administered.

Maintenance of anesthesia:

The study ends 5 min post intubation. At this time sevoflurane and fentanyl will be administered according to the patient's needs. Ventilation will be adjusted to pCO2-values in the range 4.5-6 kPa, and body temperature maintained at > 36 degree ºC with a forced-air warmer.

Monitoring:

Routine monitoring of blood pressure, ECG, and pulse oximetry, according to standard of anaesthesia, approved by the Society of the Norwegian Anaesthesiologists. An arterial line will be inserted in one of the radial arteries for accurate beat-to-beat recording of blood pressure and heart rate, and for collection of blood samples.

Statistical analysis plan:

In the present study a nonlinear logistic regression analysis will be used to determine the optimal dose of alfentanil based on the success rates of optimal blood pressure control (blood pressure increase < 10%)and the success rates of perfect intubation conditions in all alfentanil dose groups.


Recruitment information / eligibility

Status Completed
Enrollment 84
Est. completion date October 2011
Est. primary completion date September 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 55 Years
Eligibility Inclusion Criteria:

- ASA I and II patients and admitted for elective surgery.

- Aged 18-55 years

- Written informed consent

Exclusion Criteria:

- Body Mass Index (BMI) > 28 Kg/m²

- Patients with known allergy to study drug

- Patients with known porphyria

- Neuromuscular disease or undergoing treatment with drugs known to interfere with neuromuscular transmission.

- Mallampati class > 2airway anatomy, or anticipated difficulty with mask ventilation or tracheal intubation.

- Neuromuscular disease

- Pulmonary disease

- Cardiovascular disease.

Study Design

Allocation: Randomized, Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention


Related Conditions & MeSH terms

  • Anesthesia Intubation Complication

Intervention

Drug:
Alfentanil 0.5mg/ml (Rapifen , Janssen-Cilag)
Induction dose(0µg/kg,10µg/kg,20µg/kg,30µg/kg,40µg/kg,50µg/Kg,and 60µg/kg) 12 patients in each dose group. Pentothal 4mg/kg Rocuronium 0.6 mg/kg

Locations

Country Name City State
Norway Oslo University Hospital / Aker Oslo
Norway Oslo University Hospital/ Aker Oslo Akershus

Sponsors (2)

Lead Sponsor Collaborator
Oslo University Hospital University Hospital, Aker

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Primary Alfentanil and blockage of sympathetic responses: A dose-response study. Effectivness of controling Blood pressure during intubation 2 years Yes
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03591432 - A Trial Comparing Transnasal humidified Rapid insufflation Ventilatory Exchange (THRIVE) and Apneic Oxygenation With Facemask Ventilation in Elderly Patients Undergoing Induction of Anaesthesia. N/A
Recruiting NCT01790646 - Learning and Performance of Glidescope® Videolaryngoscope Intubation N/A
Not yet recruiting NCT04268043 - Comparation of Proseal Laryngeal Mask Airway With Flexible Laryngeal Airway Mask N/A
Recruiting NCT03902704 - Safety and Efficacy of Cleverscope. A New Medical Device for Tracheal Intubation N/A
Completed NCT05383417 - No Post Intubation Laryngeal Symptoms N/A
Recruiting NCT04864106 - Comprehensive Preoperative Airway Grading N/A
Active, not recruiting NCT02627755 - GlideScope® vs GlideScope® + aScope® for Managing Difficult Airways. N/A
Not yet recruiting NCT06091631 - Magnesium Sulfate in Surgical Stress Attenuation Postoperative Sore Throat and Stress Response Induced Tracheal Intubation N/A
Completed NCT04085744 - A Comparison Of Local Anesthetic Agents And Steroid On Tracheal Tube Cuff N/A
Completed NCT04802122 - Induction of Anesthesia With Sevoflurane Preserving Spontaneous Breathing: Cardiorespiratory Effects. Phase 4
Completed NCT05366582 - Neural Integrity Monitor Electromyogram (NIM-EMG) Endotracheal Tube Intubation With Video Laryngoscope N/A
Completed NCT03631875 - Co-induction Ketamine-propofol: Effects on Laryngeal Mask Airway Insertion Conditions in Children Phase 4
Completed NCT04110899 - Paratracheal Force Required for Occluding the Upper Esophagus N/A
Not yet recruiting NCT05279170 - MAsk VEntilation With Paratracheal Pressure In Children. Para Tracheal Compression to Prevent Gastric Insufflation in Children N/A
Completed NCT01289769 - The Effect of Dexmedetomidine on Hemodynamic Response During Double Lumen Endotracheal Intubation Phase 2
Completed NCT03833947 - Dexamethasone vs Bicarbonate to Intracuff Lignocaine 2% in General Anaesthesia Phase 4
Completed NCT04779528 - Awake Nasal Fiber-optic Intubation of Severely Obese Patients in Lateral Position N/A
Recruiting NCT05433155 - Nasotracheal Intubation With VL vs DL in Infants Trial N/A
Completed NCT05432570 - Use of Muscle Relaxants in Parotidectomy Operation With Neuromonitoring N/A
Completed NCT02564640 - Comparison of Hemodynamic Changes by Using the Videolaryngoscope and the Macintosh Laryngoscope N/A